Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Search content at Mayo Clinic
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Evidence lost to treatment of critically-ill patients?
M. J. Schultz
, P. E. Spronk
, B. Afessa
,
O. Gajic
Pulmonary and Critical Care Medicine
Quantitative Health Sciences
Research output
:
Contribution to journal
›
Review article
›
peer-review
3
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Evidence lost to treatment of critically-ill patients?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Acute Respiratory Distress Syndrome
100%
Glucocorticoid
100%
Health Care Cost
50%
Critical Illness
50%
Artificial Respiration
50%
Sepsis
50%
Septic Shock
50%
Insulin Treatment
50%
Activated Protein C
50%
Fluid Therapy
50%
Lung
50%
Side Effect
50%
Health Care Personnel
50%
Keyphrases
Critically Ill Patients
100%
New Therapies
75%
Acute Respiratory Distress Syndrome
50%
Glucocorticoid Therapy
50%
Decision Support
25%
Treatment Strategy
25%
Critical Illness
25%
Healthcare Workers
25%
Severe Sepsis
25%
Expert Opinion
25%
Shock
25%
Trial Protocol
25%
Intensive Insulin Therapy
25%
Lung Protective Ventilation
25%
Activated Protein C
25%
Grading Process
25%
Refractory Septic Shock
25%
Goal-directed Fluid Therapy
25%
Healthcare Quality Improvement
25%
Daily Practice
25%
Nursing and Health Professions
Adult Respiratory Distress Syndrome
100%
Glucocorticoid
100%
Health Care Personnel
50%
Critical Illness
50%
Artificial Respiration
50%
Sepsis
50%
Insulin Treatment
50%
Septic Shock
50%
Activated Protein C
50%
Fluid Therapy
50%
Side Effect
50%
Pharmacology, Toxicology and Pharmaceutical Science
Adult Respiratory Distress Syndrome
100%
Glucocorticoid
100%
Critical Illness
50%
Sepsis
50%
Septic Shock
50%
Activated Protein C
50%
Insulin
50%
Side Effect
50%